Systemic Corticosteroids for Cutaneous Immune-Related Adverse Events Do Not Impact Survival Outcomes in Advanced Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer
JAMA Dermatol 2021 Apr 14;[EPub Ahead of Print], LL Thompson, J Yoon, NA Krasnow, MS Chang, EB Li, DE McMahon, ST ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.